Stock listing
RANI Stock Price, News, Filings & Events — Rani Therapeutics Holdings, Inc.
Selected listing: RANI · NASDAQ · USD · US
This page tracks Rani Therapeutics Holdings, Inc.'s RANI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RANI:NASDAQ. RANI:NASDAQ is the stock-level entry point for investors researching Rani Therapeutics Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rani Therapeutics Holdings, Inc. is a public company traded under the ticker RANI in the American market. The company has a market capitalization of approximately $95 million. Rani Therapeutics focuses on developing innovative drug delivery systems.
- Ticker
- RANI:NASDAQ
- Asset type
- Stock
- Market cap
- $105.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Rani Therapeutics Holdings, Inc. RANI:NASDAQ stock context
This page tracks Rani Therapeutics Holdings, Inc.'s RANI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RANI:NASDAQ. RANI:NASDAQ is the stock-level entry point for investors researching Rani Therapeutics Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rani Therapeutics Holdings, Inc. is a public company traded under the ticker RANI in the American market. The company has a market capitalization of approximately $95 million. Rani Therapeutics focuses on developing innovative drug delivery systems.
Latest news from Rani Therapeutics Holdings, Inc.
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
August 13, 2026
Rani Therapeutics Appoints Michelle Gilson to Board of Directors
August 4, 2026
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 20, 2026
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding M...
July 15, 2026
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
July 9, 2026
Rani Therapeutics Holdings, Inc. earnings calls
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call
March 31, 2025 · Replay with transcript and chapters
Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call
March 20, 2024 · Replay with transcript and chapters
Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call
March 22, 2023 · Replay with transcript and chapters
Research Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. investor report
Review AI stock analysis and investor report context for RANI:NASDAQ.
Rani Therapeutics Holdings, Inc. company profile
View the public company page for Rani Therapeutics Holdings, Inc. on 6ix.
Rani Therapeutics Holdings, Inc. news
Read company news and market updates connected to Rani Therapeutics Holdings, Inc..
Rani Therapeutics Holdings, Inc. investor events
Find investor webinars, events, and replay context for Rani Therapeutics Holdings, Inc..